tailieunhanh - The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide

In patients with bone metastatic castration-resistant prostate cancer (bmCRPC) on systemic treatment, it is difficult to differentiate between continuous rise of prostate-specific antigen (PSA) representing progression, and PSA-surge, which is followed by clinical response or stable disease. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN